Prime Therapeutics buying Magellan Health's pharma business for $1.35 billion
May 05, 2022 at 12:33 PM EDT
Prime Therapeutics said the deal will lower costs by creating a new specialty drug-management model.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|